Adenosine A2B Receptor: From Cell Biology to Human Diseases
- PMID: 27606311
- PMCID: PMC4995213
- DOI: 10.3389/fchem.2016.00037
Adenosine A2B Receptor: From Cell Biology to Human Diseases
Abstract
Extracellular adenosine is a ubiquitous signaling molecule that modulates a wide array of biological processes. Recently, significant advances have been made in our understanding of A2B adenosine receptor (A2BAR). In this review, we first summarize some of the general characteristics of A2BAR, and then we describe the multiple binding partners of the receptor, such as newly identified α-actinin-1 and p105, and discuss how these associated proteins could modulate A2BAR's functions, including certain seemingly paradoxical functions of the receptor. Growing evidence indicates a critical role of A2BAR in cancer, renal disease, and diabetes, in addition to its importance in the regulation of vascular diseases, and lung disease. Here, we also discuss the role of A2BAR in cancer, renal disease, and diabetes and the potential of the receptor as a target for treating these three diseases.
Keywords: A2B adenosine receptor; binding proteins; cancer; diabetes; renal disease.
Figures
Similar articles
-
Actinin-1 binds to the C-terminus of A2B adenosine receptor (A2BAR) and enhances A2BAR cell-surface expression.Biochem J. 2016 Jul 15;473(14):2179-86. doi: 10.1042/BCJ20160272. Epub 2016 May 17. Biochem J. 2016. PMID: 27208173
-
The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.Biochem Pharmacol. 2016 Oct 1;117:46-56. doi: 10.1016/j.bcp.2016.08.007. Epub 2016 Aug 9. Biochem Pharmacol. 2016. PMID: 27520486
-
The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications.Pharmacol Ther. 2019 Jun;198:20-33. doi: 10.1016/j.pharmthera.2019.01.003. Epub 2019 Jan 22. Pharmacol Ther. 2019. PMID: 30677476 Review.
-
The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells.Front Pharmacol. 2018 Jan 31;9:54. doi: 10.3389/fphar.2018.00054. eCollection 2018. Front Pharmacol. 2018. PMID: 29445342 Free PMC article.
-
The resurgence of A2B adenosine receptor signaling.Biochim Biophys Acta. 2011 May;1808(5):1329-39. doi: 10.1016/j.bbamem.2010.05.016. Epub 2010 May 28. Biochim Biophys Acta. 2011. PMID: 20546702 Free PMC article. Review.
Cited by
-
Current Understanding of the Role of Adenosine Receptors in Cancer.Molecules. 2024 Jul 26;29(15):3501. doi: 10.3390/molecules29153501. Molecules. 2024. PMID: 39124905 Free PMC article. Review.
-
Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis.Front Pharmacol. 2017 May 5;8:243. doi: 10.3389/fphar.2017.00243. eCollection 2017. Front Pharmacol. 2017. PMID: 28529484 Free PMC article. Review.
-
2'3'-cGAMP interactome identifies 2'3'-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunity.Sci Adv. 2024 Oct 18;10(42):eado7024. doi: 10.1126/sciadv.ado7024. Epub 2024 Oct 16. Sci Adv. 2024. PMID: 39413198 Free PMC article.
-
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness.Cancers (Basel). 2022 Aug 20;14(16):4032. doi: 10.3390/cancers14164032. Cancers (Basel). 2022. PMID: 36011024 Free PMC article. Review.
-
Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction.Front Pharmacol. 2021 Aug 20;12:724320. doi: 10.3389/fphar.2021.724320. eCollection 2021. Front Pharmacol. 2021. PMID: 34489711 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources